Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 5
2016 7
2017 6
2018 5
2019 4
2020 1
2021 4
2022 4
2023 1
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Results by year

Filters applied: . Clear all
Page 1
Colistin, mechanisms and prevalence of resistance.
Bialvaei AZ, Samadi Kafil H. Bialvaei AZ, et al. Curr Med Res Opin. 2015 Apr;31(4):707-21. doi: 10.1185/03007995.2015.1018989. Epub 2015 Mar 19. Curr Med Res Opin. 2015. PMID: 25697677 Review.
Current methods for the identification of carbapenemases.
Bialvaei AZ, Kafil HS, Asgharzadeh M, Yousef Memar M, Yousefi M. Bialvaei AZ, et al. J Chemother. 2016;28(1):1-19. doi: 10.1179/1973947815Y.0000000063. J Chemother. 2016. PMID: 26256147 Review.
Epidemiological burden of Listeria monocytogenes in Iran.
Zahedi Bialvaei A, Sheikhalizadeh V, Mojtahedi A, Irajian G. Zahedi Bialvaei A, et al. Iran J Basic Med Sci. 2018 Aug;21(8):770-780. doi: 10.22038/IJBMS.2018.28823.6969. Iran J Basic Med Sci. 2018. PMID: 30186562 Free PMC article. Review.
Fosfomycin: mechanisms and the increasing prevalence of resistance.
Aghamali M, Sedighi M, Zahedi Bialvaei A, Mohammadzadeh N, Abbasian S, Ghafouri Z, Kouhsari E. Aghamali M, et al. Among authors: zahedi bialvaei a. J Med Microbiol. 2019 Jan;68(1):11-25. doi: 10.1099/jmm.0.000874. Epub 2018 Nov 15. J Med Microbiol. 2019. PMID: 30431421 Review.
Linezolid: a promising option in the treatment of Gram-positives.
Zahedi Bialvaei A, Rahbar M, Yousefi M, Asgharzadeh M, Samadi Kafil H. Zahedi Bialvaei A, et al. J Antimicrob Chemother. 2017 Feb;72(2):354-364. doi: 10.1093/jac/dkw450. Epub 2016 Dec 20. J Antimicrob Chemother. 2017. PMID: 27999068 Review.
Therapeutic bacteria to combat cancer; current advances, challenges, and opportunities.
Sedighi M, Zahedi Bialvaei A, Hamblin MR, Ohadi E, Asadi A, Halajzadeh M, Lohrasbi V, Mohammadzadeh N, Amiriani T, Krutova M, Amini A, Kouhsari E. Sedighi M, et al. Among authors: zahedi bialvaei a. Cancer Med. 2019 Jun;8(6):3167-3181. doi: 10.1002/cam4.2148. Epub 2019 Apr 5. Cancer Med. 2019. PMID: 30950210 Free PMC article. Review.
Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990-2021: a systematic analysis from the Global Burden of Disease Study 2021.
GBD 2021 Lower Respiratory Infections and Antimicrobial Resistance Collaborators. GBD 2021 Lower Respiratory Infections and Antimicrobial Resistance Collaborators. Lancet Infect Dis. 2024 Apr 15:S1473-3099(24)00176-2. doi: 10.1016/S1473-3099(24)00176-2. Online ahead of print. Lancet Infect Dis. 2024. PMID: 38636536 Free article.
35 results